+$12.1M
Net Activity
Institutions Holding
26
Popularity Rank
#7631
Avg Weight
0.03%
Total Value
$20.2M
26 institutions currently hold NTHI, with 12 net buyers and 9 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
9
Net Buying Institutions
12
Top 5 by Value
+$15.8M
Total Buy Value
$2.3M
Total Sell Value
12
Net Buyers
9
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
2
Filings (14d)
NeOnc Technologies Holdings announced on July 15, 2026 that it received written feedback from the FDA regarding the chemistry, manufacturing, and controls (CMC) program for its drug candidate NEO212. The company issued a press release detailing the update. This feedback is part of the standard regulatory process and provides guidance on manufacturing requirements.
View Full Filing (SEC EDGAR)NeOnc Technologies Holdings, Inc. announced the resignation of director Ming-Fu (Alan) Chiang effective June 27, 2026, who also left the Scientific Advisory Board. The company appointed Nasim Shomali as a Class II director on July 1, 2026, to serve until the 2027 annual meeting. Shomali is the niece of the company's President, CEO, and Executive Chairman, Amir Heshmatpour, and has a background as a strategy executive at Accenture.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter